Cytogenetic biomonitoring in mucopolyssacharosis I, II and IV patients treated with enzyme replacement therapy

References

• Angelieri A, Oliveira GR, Sannomiya EK, Ribeiro DA. (2007). DNA damage and cellular death in oral mucosa cells of children who have undergone panoramic dental radiography. Ped Radiol 37:561–5
   PubMed Web of Science ®Google Scholar
• Beliën JA, Copper MP, Braakhuis BJ, et al. (1995). Standardization of counting micronuclei, definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis 16:2395–400
   PubMed Web of Science ®Google Scholar
• Buajeeb W, Kraivaphan P, Amornchat C, Triratana T. (2007). Frequency of micronucleated exfoliated cells in oral lichen planus. Mutat Res 627:191–6
   PubMed Web of Science ®Google Scholar
• Campos D, Monaga M. (2012). Mucopolysaccharidosis type I, current knowledge on its pathophysiological mechanisms. Metab Brain Dis 27:121–9
   PubMed Web of Science ®Google Scholar
• Christianto A, Watanabe H, Nakajima T, Inazu T. (2013). Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene. Clin Chim Acta 423:66–8
   PubMed Web of Science ®Google Scholar
• Coelho JC, Wajner M, Burin MG, et al. (1997). Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr 156:650–4
   Google Scholar
• Cohen DM, Mourao PA, Dietrich CP. (1977). Differentiation of mucopolysaccharidoses by analyses of the excreted sulfated mucopolysaccharides. Clin Chim Acta 80:555–62
   PubMed Web of Science ®Google Scholar
• Desnick RJ. (2004). Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27:385–410
   PubMed Web of Science ®Google Scholar
• Filippon L, Wayhs CA, Atik DM, et al. (2011). DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients, protective effect of enzyme replacement therapy. Mutat Res 721:206–10
   PubMed Web of Science ®Google Scholar
• He JL, Chen LF, Jin LF, Jin HY. (2000). Comparative evaluation of the in vitro micronucleus test and the comet assay for the detection of genotoxic effects of X-ray radiation. Mutat Res 469:223–31
   PubMed Web of Science ®Google Scholar
• Jagetia GC, Jayakrishnan A, Fernandes D, Vidyasagar MS. (2001). Evaluation of micronuclei frequency in the cultured peripheral blood lymphocytes of cancer patients before and after radiation treatment. Mutat Res 491:9–16
   PubMed Web of Science ®Google Scholar
• Kujan O, Oliver RJ, Khattab A, et al. (2006). Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 42:987–93
   PubMed Web of Science ®Google Scholar
• Mally A, Jagetia JK. (2002). Non-genotoxic carcinogens, early effects on gap junctions, cell proliferation and apoptosis in the rat. Toxicology 180:233–48
   PubMed Web of Science ®Google Scholar
• Müller KB, Rodrigues MD, Pereira VG, et al. (2010). Reference values for lysosomal enzymes activities using dried blood spots samples – a Brazilian experience. Diagn Pathol 5:65
   PubMed Web of Science ®Google Scholar
• Nelson J. (1997). Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 101:355
   PubMed Web of Science ®Google Scholar
• Neufeld EF, Muenzer J. (2001). The mucopolysaccharidoses. In Scriver CR, Sly WS, ed. The metabolic and molecular bases of inherited disease. New York: McGraw Hill, 3421–52
   Google Scholar
• Noguti J, Pereira VG, Martins AM, et al. (2011). Genomic instability in blood cells from murine model of mucopolysaccharidosis type I. J Mol Histol 42:575–8
   PubMed Web of Science ®Google Scholar
• Pereira VG, Martins AM, Micheletti C, D'Almeida V. (2008). Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy. Clin Chim Acta 387:75–9
   PubMed Web of Science ®Google Scholar
• Perenc L. (2013). Anthropometric characteristics of four Polish children with mucopolysaccharidosis. BMC Res Notes 6:246
   PubMedGoogle Scholar
• Ribas GS, Manfredini V, de Marco MG, et al. (2010). Prevention by l-carnitine of DNA damage induced by propionic and L-methylmalonic acids in human peripheral leukocytes in vitro. Mutat Res 702:123–8
   PubMed Web of Science ®Google Scholar
• Sitta A, Manfredini V, Biasi L, et al. (2009). Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat Res 679:13–16
   PubMed Web of Science ®Google Scholar
• Sugano N, Minigeshi T, Kawamoto K, Ito K. (2001). Nicotine inhibits UV-induced activation of the apoptotic pathway. Toxicol Lett 125:61–5
   PubMed Web of Science ®Google Scholar
• Swenberg JA. (1993). Cell proliferation and chemical carcinogenesis, conferences summary and future directions. Environ Health Perspect 101:153–8
   PubMed Web of Science ®Google Scholar
• Terman A, Kurz T, Gustafsson B, Brunk UT. (2006). Lysosomal labilization. IUBMB Life 58:531–9
   PubMed Web of Science ®Google Scholar
• Tice RR, Agurell E, Anderson D, et al. (2000). Single cell gel/comet assay, guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–21
   PubMed Web of Science ®Google Scholar
• Tolbert PE, Shy CM, Allen JW. (1992). Micronuclei and other nuclear anomalies in buccal smears, methods development. Mutat Res 271:69–77
   PubMed Web of Science ®Google Scholar
• Tomatsu S, Fujii T, Fukushi M, et al. (2013). Newborn screening and diagnosis of mucopolysaccharidoses. Mol Genet Metab 110:42–53
   PubMed Web of Science ®Google Scholar
• Torres-Bugárin O, Ventura-Aguilar A, Zamora-Pilar A, et al. (2003). Evaluation of cisplatin +5-FU, carboplatin +5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in buccal mucosa. Mutat Res 539:177–86
   PubMed Web of Science ®Google Scholar
• Valayannopoulos V, Nicely H, Harmatz P, Turbeville S. (2010). Mucopolysaccharidosis VI. Orphanet J Rare Dis 5:5
   PubMed Web of Science ®Google Scholar
• Wajner A, Michelin K, Burin MG, et al. (2004). Biochemical characterization of chitotriosidase enzyme, comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases. Clin Biochem 37:893–7
   PubMed Web of Science ®Google Scholar